Blog

NEW YORK CITY, NY AND AUSTIN, TX / ACCESS Newswire / June 13, 2025 / Terra Innovatum Srl (“Terra Innovatum,” or the “Company”), a developer of micro-modular nuclear reactors, and GSR III Acquisition Corp. (Nasdaq:GSRT), a publicly traded special purpose acquisition company, today announced that Terra Innovatum will host a Virtual Investor Day on Wednesday, June 25, 2025, from 9:00 a.m. to 11:00 a.m. Eastern Time.

The leadership teams from Terra Innovatum and GSR III Acquisition Corp. will present an in-depth overview of their proposed business combination, aimed at bringing Terra Innovatum public on Nasdaq, and the Company’s unique technology, its market opportunity, regulatory plan, and go-to-market strategy. The presentation will be followed by a moderated question and answer session.

The event will be streamed live and we highly encourage prospective investors, analysts, and the financial media to register for the event here.

A webcast reply will be available on the investors section of Terra Innovatum’s website at https://www.x-solo.com/investors 24 hours after the event.

In Picture: Giordano Morichi – Partner, Chief Business Development Officer & Investor Relations at Terra Innovatum in London during investor meetings.

15^th Annual ROTH London Conference on June 26, 2025

Members of the management teams of Terra Innovatum and GSR III Acquisition Corp. will host one-on-one investor meetings at the 15^th Annual ROTH London Conference, located at the Four Seasons Hotel London at Park Lane, on Thursday, June 26, 2025.

Due to anticipated high demand, we kindly recommend reaching out to a ROTH representative or TerraIR@allianceadvisors.com to secure a meeting in advance.

Recent Highlights

Terra Innovatum recently announced a proposed business combination with GSR III Acquisition Corp., positioning the Company to accelerate its mission of delivering zero-carbon, cost-efficient, and reliable power. SOLO™ is the first micro-modular reactor designed to operate on widely available Low-Enriched Uranium (LEU) and is built using commercial off-the-shelf components, streamlining regulatory review and shortening construction timelines. To date, the Company has demonstrated strong market momentum, including a strategic partnership with Paragon Energy Solutions to support its global deployment and submittal of an advanced nuclear proposal to the New York State Energy Research and Development Authority’s Advanced Nuclear Request for Information, outlining plans for a potential reactor site, production facility, and deployment opportunities to address New York’s 2040 zero-carbon goal. Earlier this year, Terra Innovatum submitted its regulatory engagement plan to the U.S. Nuclear Regulatory Commission (NRC), a critical step toward its targeted first commercial deployment in 2028.

ABOUT TERRA INNOVATUM & SOLO^TM

Terra Innovatum’s mission is to make nuclear power accessible. We deliver simple and safe micro-reactor solutions that are scalable, affordable and deployable anywhere – 1 MWe at a time.

Terra Innovatum is a pioneering force in the energy sector, dedicated to delivering innovative and sustainable power solutions. Terra Innovatum plans to leverage cutting-edge nuclear technology through the SOLO™ Micro-Modular Reactor (SMR™) to provide efficient, safe, and environmentally conscious energy. With a mission to address global energy shortages, Terra Innovatum combines extensive expertise in nuclear industry design, manufacturing, and installation licensing to offer disruptive energy solutions. Committed to propelling technological advancements, Terra Innovatum and SOLO™ are dedicated to fostering prosperity and sustainability for humankind.

It is anticipated that SOLO™ will be available globally within the next three years. Conceptualized in 2018 and engineered over six years by experts in nuclear safety, licensing, innovation, and R&D, SOLO™ addresses pressing global energy demands with a market-ready solution. Built from readily available commercial off-the-shelf components, the proven licensing path for SOLO™ enables rapid deployment and minimizes supply chain risks, ensuring final cost predictability. Designed to adapt with evolving fuel options, SOLO™ supports both LEU+ and HALEU, offering a platform ready to transition to future fuel supplies.

SOLO™ will offer a wide range of versatile applications, providing CO2-free, behind-the-meter, and off-grid power solutions for data centers, mini-grids serving remote towns and villages, and large-scale industrial operations in hard-to-abate sectors like cement production, oil and gas, steel manufacturing, and mining. It also has the ability to supply heat for industrial applications and other specialized processes, including water treatment, desalination and co-generation. Thanks to its modular design, SOLO™ can easily scale to deliver up to 1GW or more of CO2-free power with a minimal footprint, making it an ideal solution for rapidly replacing fossil fuel-based thermal plants. Beyond electricity and heat generation, SOLO™ can also contribute to critical applications in the medical sector by producing radioisotopes essential for oncology research and cancer treatment.

To learn more, visit: www.x-solo.com

ABOUT GSR III

GSR III Acquisition Corp. is a blank check company incorporated in the Cayman Islands with the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more operating businesses. GSRT is led by a highly experienced sponsor team with a strong track record in SPAC transactions, having previously sponsored two SPACs and advised on over 20 successful SPAC completions. The company’s management team includes Co-Chief Executive Officers Mr. Gus Garcia and Mr. Lewis Silberman, President and Chief Financial Officer Mr. Anantha Ramamurti, and Chief Business Development Officer Mr. Yuya Orime.

IMPORTANT INFORMATION FOR SHAREHOLDERS

This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or constitute a solicitation of any vote or approval.

In connection with the business combination, a Dutch public limited liability company (“Pubco”), GSR III Acquisition Corp. (“GSRT”) and Terra Innovatum s.r.l. (“Terra Innovatum” and, together with GSR III and Pubco, the “Registrant Parties”) have filed with the SEC a registration statement on Form S-4 (the “Registration Statement”), which includes a preliminary prospectus of Pubco relating to the offer of securities to be issued in connection with the business combination, and a preliminary proxy statement of GSRT to be distributed to holders of GSRT’s ordinary shares in connection with GSRT’s solicitation of proxies for a vote by GSRT’s shareholders with respect to the Business Combination and other matters described in the Registration Statement. The Registrant Parties also plan to file other documents with the SEC regarding the business combination. After the Registration Statement has been declared effective by the SEC, a definitive proxy statement/prospectus will be mailed to the shareholders of GSRT. INVESTORS OF THE REGISTRANT PARTIES ARE URGED TO READ THE REGISTRATION STATEMENT, THE PROXY STATEMENT/PROSPECTUS CONTAINED THEREIN (INCLUDING ALL AMENDMENTS AND SUPPLEMENTS THERETO) AND ALL OTHER DOCUMENTS RELATING TO THE BUSINESS COMBINATION THAT WILL BE FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE BUSINESS COMBINATION.

Investors will be able to obtain free copies of the proxy statement/prospectus and other documents containing important information about the Registrant Parties once such documents are filed with the SEC, through the website maintained by the SEC at http://www.sec.gov. In addition, the documents filed by GSRT may be obtained free of charge by written request to GSRT at 5900 Balcones Drive, Suite 100, Austin TX 78731.

PARTICIPANTS IN THE SOLICITATION

Each of the Registrant Parties, and their respective directors and executive officers, may be considered participants in the solicitation of proxies with respect to the potential transaction described in this communication under the rules of the SEC. Information about the directors and executive officers of GSRT is set forth in GSRT’s filings with the SEC. Information regarding other persons who may, under the rules of the SEC, be deemed participants in the solicitation of the shareholders in connection with the potential transaction and a description of their direct and indirect interests will be set forth in the Registration Statement (and will be included in the proxy statement/prospectus) and other relevant documents when they are filed with the SEC. These documents can be obtained free of charge from the sources indicated above.

FORWARD LOOKING STATEMENTS

The statements contained in this press release that are not purely historical are forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding our expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.

The forward-looking statements contained in this press release are based on our current expectations and beliefs concerning future developments and their potential effects on GSRT and the other Registrant Parties. There can be no assurance that future developments affecting GSRT and the other Registrant Parties will be those that we have anticipated. These forward-looking statements speak only as of the date this press release is delivered and involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the definitive agreements with respect to the Business Combination; (2) the outcome of any legal proceedings that may be instituted against GSRT, any of the Registrant Parties, the combined company or others following the announcement of the Business Combination and any definitive agreements with respect thereto; (3) the inability to complete the Business Combination due to the failure to obtain approval of the shareholders of GSRT or the SEC’s declaration of the effectiveness of the Registration Statement (which will include the proxy statement/prospectus contained therein) to be filed by the Registrant Parties or to satisfy other conditions to closing; (4) changes to the proposed structure of the Business Combination that may be required or appropriate as a result of applicable laws or regulations or as a condition to obtaining regulatory approval of the Business Combination; (5) the ability of Pubco to meet stock exchange listing standards following the consummation of the Business Combination; (6) the risk that the Business Combination disrupts current plans and operations of Terra Innovatum as a result of the announcement and consummation of the Business Combination; (7) the ability to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; (8) costs related to the Business Combination, including the reorganization described in the business combination agreement; (9) changes in applicable laws or regulations; (10) the possibility that the Registrant Parties or the combined company may be adversely affected by other economic, business, and/or competitive factors; (11) the amount of redemption requests made by GSRT shareholders and (12) other risk factors described herein as well as the risk factors and uncertainties described in the Form S-4 and GSRT’s other filings with the SEC, as well as any further risks and uncertainties to be contained in the proxy statement/prospectus filed after the date hereof. In addition, there may be additional risks that neither GSRT nor any of the other Registrant Parties presently know, or that GSRT or the other Registrant Parties currently believe are immaterial, that could also cause actual results to differ from those contained in the forward-looking statements. Nothing in this communication should be regarded as a representation by any person that the forward- looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made.

None of GSRT, the other Registrant Parties, or any of their respective affiliates, officers, employees or agents, makes any representation or warranty, either express or implied, in relation to the fairness, reasonableness, adequacy, accuracy, completeness or reliability of the information, statements or opinions, whichever their source, contained in this press release or any oral information provided in connection herewith, or any data it generates and accept no responsibility, obligation or liability (whether direct or indirect, in contract, tort or otherwise) in relation to any of such information. GSRT, the other Registrant Parties and their respective affiliates, officers, employees and agents further expressly disclaim any and all liability relating to or resulting from the use of this press release and any errors therein or omissions therefrom. Further, the information contained herein is preliminary, is provided for discussion purposes only, is only a summary of key information, is not complete and is subject to change without notice.

In addition, the information contained in this press release is provided as of the date hereof and may change, and neither GSRT nor the other Registrant Parties undertakes any obligation to update or revise any forward- looking statements, whether as a result of new information, inaccuracies, future events or otherwise, except as may be required under applicable securities laws.

CONTACTS

Giordano Morichi
Partner, Chief Business Development Officer & Investor Relations
Terra Innovatum Srl
E: g.morichi@terrainnovatum.com
W: www.x-solo.com

Anantha Ramamurti
President, Chief Financial Officer
GSR III Acquisition Corp
E: anantha@gsrspac.com
P: (949) 468-7434STA

Nicholas Hresko-Staab
Investor & Media Relations
Alliance Advisors IR
E: TerraIR@allianceadvisors.com

SOURCE: TERRA INNOVATUM SRL

View the original press release on ACCESS Newswire

Clear Start Tax Reveals How Hidden Red Flags in IRS Records Can Trigger Enforcement – and Why Reviewing Your Transcript Is the First Step Toward Resolution

IRVINE, CA / ACCESS Newswire / June 13, 2025 / For many taxpayers, the term “IRS transcript” sounds like a dry document meant for accountants or audits. But according to Clear Start Tax, this internal report could be the most important tool in identifying what the IRS knows, what they’re watching, and what may be coming next.

Often overlooked or misunderstood, a tax transcript is a line-by-line history of how the IRS sees your account, and it’s where red flags, errors, and silent collection activity first appear.

“A lot of people wait for a scary IRS letter in the mail,” said the Head of Client Solutions at Clear Start Tax. “But by the time the letter arrives, the IRS may have already made a move. The transcript tells the story before enforcement begins if you know how to read it.”

What Is an IRS Tax Transcript – and Why It Matters

An IRS tax transcript is a downloadable record that shows return information, wage reporting, payment history, refund activity, and internal IRS codes tied to collections or audits. Clear Start Tax says it’s one of the first documents they pull when reviewing a client’s case.

Taxpayers can request their transcript online at irs.gov/transcript or by submitting Form 4506-T. There are several types, but the Account Transcript and Wage & Income Transcript are often the most revealing.

What Red Flags Could Be Hiding Inside

Clear Start Tax warns that IRS systems rely heavily on automation, and transcripts can silently show when a taxpayer’s account is being reviewed, flagged, or prepared for enforcement.

Key signs that may appear in a transcript:

• Transaction codes showing levy or lien preparation

• Missing filings or unreported 1099/W-2 income

• Refund holds or offsets due to outstanding balances

• Substitute for Return (SFR) assessments when no return is filed

• Payment reversals or dishonored payments the IRS sees as non-compliance

“We’ve seen transcripts where the client had no idea they were on track for garnishment,” said the Head of Client Solutions at Clear Start Tax. “But the IRS had already processed flags and updated their status behind the scenes.”

Errors You Might Not Know Exist

Many clients are shocked to learn that their transcripts contain clerical mistakes, misapplied payments, or unfiled returns they thought were submitted. In some cases, wage data is incorrect, or the IRS has assessed tax based on substitute returns without deductions, inflating the amount owed.

These inaccuracies can cause enforcement to escalate, even when the taxpayer thought they were compliant.

By answering a few simple questions, taxpayers can find out if they’re eligible for the IRS Fresh Start Program and take the first step toward resolving their tax debt.

How Clear Start Tax Uses Transcripts to Protect Clients

Clear Start Tax begins every resolution case with a full transcript audit, reviewing IRS activity, matching it with client documentation, and identifying risks before they lead to liens or levies. This proactive approach allows their team to:

• Flag inaccurate balances or dates

• Correct reporting issues and reestablish compliance

• Identify program eligibility (like Fresh Start or hardship status)

• Halt enforcement by addressing problems early

About Clear Start Tax

Clear Start Tax is a full-service tax liability resolution firm that serves taxpayers throughout the United States. The company specializes in assisting individuals and businesses with a wide range of IRS and state tax issues, including back taxes, wage garnishment relief, IRS appeals, and offers in compromise. Clear Start Tax helps taxpayers apply for the IRS Fresh Start Program, providing expert guidance in tax resolution. Fully accredited and A+ rated by the Better Business Bureau, the firm’s unique approach and commitment to long-term client success distinguish it as a leader in the tax resolution industry.

Need Help With Back Taxes?

Click the link below:
https://clearstarttax.com/qualifytoday/
(888) 710-3533

Contact Information

Clear Start Tax
Corporate Communications Department
seo@clearstarttax.com
(949) 535-1627

SOURCE: Clear Start Tax

View the original press release on ACCESS Newswire

AUSTIN, TX / ACCESS Newswire / June 13, 2025 / Interactive Strength Inc. (NASDAQ:TRNR) (“TRNR” or the “Company”), maker of innovative specialty fitness equipment under the CLMBR and FORME brands and pending acquirer of Sportstech and Wattbike, today announced that it has updated its investor FAQ’s on its investor website in response to shareholder questions on the recent announcement about its AI-focused $FET Treasury strategy.

For more commentary, information and details on the rationale for and structure of the expected acquisition, please see TRNR’s investor presentation on the Company’s investor website as well as its required filings with the US Securities & Exchange Commission (SEC).

TRNR Investor Contact
ir@interactivestrength.com

About Interactive Strength Inc.:

Interactive Strength Inc. produces innovative specialty fitness equipment and digital fitness services under two main brands: 1) CLMBR and 2) FORME. Interactive Strength Inc. is listed on NASDAQ (symbol:TRNR).

CLMBR is a vertical climbing machine that offers an efficient and effective full-body strength and cardio workout. CLMBR’s design is compact and easy to move – making it perfect for commercial or in-home use. With its low impact and ergonomic movement, CLMBR is safe for most ages and levels of ability and can be found at gyms and fitness studios, hotels, and physical therapy facilities, as well as available for consumers at home. www.clmbr.com.

FORME is a digital fitness platform that combines premium smart gyms with live virtual personal training and coaching to deliver an immersive experience and better outcomes for both consumers and trainers. FORME delivers an immersive and dynamic fitness experience through two connected hardware products: 1) The FORME Studio Lift (fitness mirror and cable-based digital resistance) and 2) The FORME Studio (fitness mirror). In addition to the company’s connected fitness hardware products, FORME offers expert personal training and health coaching in different formats and price points through Video On-Demand, Custom Training, and Live 1:1 virtual personal training. www.formelife.com.

Forward Looking Statements:
This press release includes certain statements that are “forward-looking statements” for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements do not relate strictly to historical or current facts and reflect management’s assumptions, views, plans, objectives and projections about the future. Forward-looking statements generally are accompanied by words such as “believe”, “project”, “expect”, “anticipate”, “estimate”, “intend”, “strategy”, “future”, “opportunity”, “plan”, “may”, “should”, “will”, “would”, “will be”, “will continue”, “will likely result” or similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding the possibility of acquiring future businesses or completing the referenced pending transactions in a timely manner or at all, the ultimate gross proceeds of the financing, the Company having the largest US publicly listed crypto treasury focused on an AI-token, and the financing strengthening the Company’s financial flexibility, supporting the Company’s AI and digital fitness ambitions, and increasing shareholder exposure to next-generation growth assets. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of the Company. Risks and uncertainties include but are not limited to: whether ATW Partners and / or DWF Labs will invest further amounts, other US publicly listed companies’ crypto strategies, and the price of $FET tokens. A further list and descriptions of these risks, uncertainties and other factors can be found in filings with the Securities and Exchange Commission. To the extent permitted under applicable law, the Company assumes no obligation to update any forward-looking statements.

# # #

SOURCE: Interactive Strength Inc.

View the original press release on ACCESS Newswire

WHITBY, ON / ACCESS Newswire / June 13, 2025 / Consumer Choice Award (CCA) is proud to announce that The Shawn Lepp Group | Keller Williams Energy Lepp Group Real Estate has been named the 2025 Consumer Choice Award Winner in the Residential Real Estate category for the Durham Region. This recognition highlights the group’s proven track record, expert leadership, and commitment to delivering superior service to buyers and sellers alike.

Led by real estate veteran Shawn Lepp, the team has earned a reputation as one of the most effective and trusted in the Durham Region. With more than 100 years of combined experience and over 120 homes sold annually, the group is known for its strategic approach, expert market knowledge, and personalized client care. Each member of the team is a licensed professional, supported by a dedicated staff that ensures every transaction runs smoothly.

“We are incredibly honoured to receive the Consumer Choice Award,” said Shawn Lepp. “This recognition reflects the hard work of our team and the trust our clients place in us every day. Helping people achieve their real estate goals is our passion, and we’re proud to serve the Durham Region with integrity and professionalism.”

At The Shawn Lepp Group, cutting-edge technology and strategic marketing come together to deliver exceptional results. From high-quality photography and video tours to targeted digital advertising and social media exposure, every listing is showcased to attract maximum attention. With data-driven insights and innovative tools, the team ensures your home reaches the right buyers at the right time-helping you sell faster and for top value.

The Shawn Lepp Group offers:

• Residential property buying and selling services

• Strategic marketing and staging consultations

• Neighbourhood insights and local expertise

• Expert negotiation and transaction support

• Personalized guidance throughout the entire real estate journey

The group’s success is built on results and relationships. Whether guiding first-time homebuyers or helping families upgrade or downsize, The Shawn Lepp Group delivers customized solutions that align with each client’s unique needs.

Clients consistently praise the team for its responsiveness, transparency, and depth of market insight-qualities that set it apart in a competitive industry. With a clear commitment to excellence, The Shawn Lepp Group continues to raise the standard for real estate service in the Durham Region.

To learn more about The Shawn Lepp Group or to book a consultation, CLICK HERE or visit www.shawnlepp.com.

About Consumer Choice Award:
Consumer Choice Award has been recognizing and promoting business excellence in North America since 1987. Its rigorous selection process ensures that only the most outstanding service providers in each category earn this prestigious recognition. Visit www.ccaward.com to learn more.

Contact Information:
Sumi Saleh
Communications Manager
ssaleh@ccaward.com

SOURCE: Consumer Choice Award

View the original press release on ACCESS Newswire

BURLINGTON, ON / ACCESS Newswire / June 13, 2025 / Safe ‘N’ Sound Environmental Services Ltd., a Burlington-based environmental remediation firm, has been recognized with the 2025 Consumer Choice Award in the Asbestos Removal category in the Halton Region. This distinction highlights the company’s commitment to providing safe, effective, and fully certified environmental solutions for both residential and commercial clients.

Founded in 2019, Safe ‘N’ Sound Environmental Services has earned a strong reputation for delivering professional asbestos abatement, mold remediation, environmental testing, and hazardous materials management. The company’s team of licensed and trained professionals ensures that each project meets regulatory compliance and exceeds safety expectations.

“Winning the Consumer Choice Award is a testament to our team’s dedication to creating safer environments,” said Michael Rocha, Owner of Safe ‘N’ Sound Environmental Services Ltd. “We take great pride in the trust our clients place in us, and we’re committed to upholding that trust through every project we take on.”

Comprehensive Environmental Services
Safe ‘N’ Sound Environmental Services offers a broad range of remediation and testing services designed to protect the health and safety of property occupants. Their service areas span across Southern Ontario, including homes, businesses, schools, industrial sites, and government buildings.

Core services include:

• Asbestos Testing and Abatement (Types 1, 2, and 3)

• Mold Testing and Remediation

• Air Quality and Bulk Sampling

• Lead and Vermiculite Removal

• Clean Demolition and Site Clearing

• Drug Lab and Biohazard Clean-up

• COVID-19 Sanitizing and Disinfection

• Respiratory Fit Testing

• Certified Training: Asbestos 253W, 253S, WHMIS, Mold Awareness

Each project begins with a thorough consultation and is executed with precision, transparency, and compliance. The team uses advanced equipment, industry-approved methods, and follows all Ministry of Labour regulations to ensure work is completed safely and effectively.

Respected by Industry Leaders and Homeowners Alike
Safe ‘N’ Sound Environmental Services has been a four-time recipient of the Halton Business Excellence Award and is widely known as a trusted name among homeowners, contractors, and developers. The company is also a preferred environmental contractor for Bryan Baeumler, a well-known Canadian builder and television personality-reinforcing its status as a respected and skilled remediation partner.

Client reviews regularly highlight the company’s professionalism, quick turnaround times, and commitment to delivering peace of mind in high-stakes environments.

Advancing Environmental Safety
With this latest recognition, Safe ‘N’ Sound Environmental Services Ltd. remains focused on expanding its reach and reinforcing its role as a leader in environmental safety across Southern Ontario. The company plans to continue developing specialized services and growing its team of certified professionals to meet rising demand for safe demolition, hazard containment, and indoor environmental quality.

“We understand the responsibility that comes with what we do,” added Rocha. “Whether it’s a family home or a large commercial site, our mission stays the same: protect people, follow the science, and deliver solutions that last.”

To learn more about Safe ‘N’ Sound Environmental Services Ltd. and their range of services, CLICK HERE or visit www.safensoundenvironmentalservices.ca.

About Consumer Choice Award:
Consumer Choice Award has been recognizing and promoting business excellence in North America since 1987. Its rigorous selection process ensures that only the most outstanding service providers in each category earn this prestigious recognition. Visit www.ccaward.com to learn more.

Contact Information:
Sumi Saleh
Communications Manager
ssaleh@ccaward.com

SOURCE: Consumer Choice Award

View the original press release on ACCESS Newswire

PIONEERTOWN, CA / ACCESS Newswire / June 13, 2025 / ESCAPE Records releases two transcendent works from its secretive Mojave Desert hub in Pioneertown CA: the Parallel Universe EP, a genre-defying musical odyssey from touring electronic artists and industry veterans, and Gong Song! (Live from Escape, Pioneertown CA), a 45-minute sound healing masterpiece by Alessandra Montana.

Crafted where social media fades to the obscure and creativity thrives, these two new records aim to forge deep audience connections – inspiring a sense of solidarity between the creative and their audience.

The Parallel Universe EP blends electronic, Americana, and Latin vibes, born during a songwriting retreat at ESCAPE’s legendary studio, some 40 miles from the gates of Coachella in the high desert of California, a mile above sea level under a myriad of stars. Listeners are invited to ponder what their life would be like in a parallel universe; evoking poignant emotions in today’s somewhat turbulent world.

Tracks are shared by studio founder and producer ROC Gardner, Latin Grammy-nominated Cimafunk (La Vida), Jamie N Commons (Hold Me While You Wait), DJ Tennis (Life and Death), and Grammy-nominated Jan Blomqvist (Remote Control), joined by producers Joseph Ray (Nero), Daniel Cantisani, Nikko Gibler (Ricoshēi), and Devlin Thorn alongside artists that include Kim Bullard (Elton John) and Craig McClune (David Gray) who lent their expertise to evolving the tracks.

Mixed by Mick Guzauski (Daft Punk, The Weeknd, Michael Jackson) and mastered by Bernie Grundman, tracks include Mezcalita (June 13), Happy Unhappy (June 20), La Sugar (June 27), and Never Know (July 4). BEEPLE’s surreal artwork Naturally Occurring Emoji and an AI-driven video by The Dor Brothers amplify the EP’s cosmic narrative.

“The universal sky we spent each night under sparked something raw,” says ROC. “It was awesome breaking out of our channels – we got to capture all these ideas, unbound by trends or any other concerns – it was great fun!”

Simultaneously, Alessandra Montana’s Gong Song! (Live from Escape) captures a live 45-minute sound journey, recorded meticulously with vintage gear and microphones at ESCAPE. Guided by mixing engineer Rob Columbus and mastered by Grundman, Montana’s gongs and sacred instruments weave a meditative portal for healing.

“Escape’s magic let me share my practice globally. I can’t wait for people to hear this and experience the journey we went on,” says Montana.

ESCAPE, a 140-acre creative haven hosting Rüfüs Du Sol, Arctic Monkeys, Usher, RAYE – and many others – fosters unfiltered artistry. The studio hopes to deliver magic – and its music – unfettered and unfiltered.

Visit www.esca.pe for more.

Assets: Press release, artwork, lyrics, .wav files available upon request.
Interviews: info@esca.pe

Jan Blomqvist appears courtesy of Armada Music B.V.

Tracks:

Mezcalita (1st Single): https://audiosalad.ffm.to/commons-roc-mezcalita

Parallel Universe EP: https://audiosalad.ffm.to/parallel-universe

Gong Song! (Live from Escape): https://audiosalad.ffm.to/gong-song

SOURCE: Escape Records LLC

Related Images

View the original press release on ACCESS Newswire

Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older

CAMBRIDGE, MA / ACCESS Newswire / June 12, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA® (mRNA-1345), the Company’s respiratory syncytial virus (RSV) vaccine, for the prevention of lower respiratory tract disease (LRTD) caused by RSV in individuals 18-59 years of age who are at increased risk for disease. This approval expands the previous indication of mRESVIA, which was approved in May 2024 for adults aged 60 years and older.

“RSV poses a serious health risk to adults with certain chronic conditions, and today’s approval marks an important step forward in our ability to protect additional populations from severe illness from RSV,” said Stéphane Bancel, Chief Executive Officer of Moderna. “We appreciate the FDA’s review and thank all the participants in our clinical trial as well as the Moderna team for their dedication to protecting people against RSV.”

While the risk of RSV is well recognized in infants and older adult populations, adults aged 18-59 years with chronic conditions are also vulnerable.¹ Over one-third of adults aged 18-59 years have at least one underlying condition that puts them at increased risk of severe RSV disease,² with disease burden and hospitalization rates in this population being comparable, or even exceeding, that observed in older adults.³

This approval was supported by results from Moderna’s Phase 3 study (NCT06067230), which evaluated the safety and immunogenicity of mRESVIA in adults aged 18-59 with underlying health conditions. The immune responses against both RSV-A and RSV-B met prespecified non-inferiority immunobridging criteria when compared to those observed in adults aged 60 years and older in the pivotal Phase 3, placebo-controlled safety and efficacy study. Comparable levels of neutralizing antibodies were observed across both the 18-49 and 50-59 age subgroups, supporting the vaccine’s consistent immunogenicity profile in this at-risk, younger adult population. These findings were presented at the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) meeting in April 2025 and have been published in Clinical Infectious Diseases.

The vaccine was generally well-tolerated, and the most commonly reported solicited adverse reactions were injection site pain, fatigue, headache, myalgia and arthralgia.

Moderna intends to have mRESVIA available for both younger adults at increased risk (ages 18-59) and older adults (ages 60+) in the U.S. for the 2025-2026 respiratory virus season.

About mRESVIA® (Respiratory Syncytial Virus Vaccine)

mRESVIA® is an RSV vaccine that consists of an mRNA sequence encoding a stabilized prefusion F glycoprotein. The F glycoprotein is expressed on the surface of the virus and is required for infection by helping the virus to enter host cells. The prefusion conformation of the F protein is a significant target of potent neutralizing antibodies and is highly conserved across both RSV-A and RSV-B subtypes. The vaccine uses the same lipid nanoparticles (LNPs) as the Moderna COVID-19 vaccines.

About Moderna

Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.

Moderna’s mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.

mRESVIA® is a registered trademark of Moderna.

INDICATION
mRESVIA is a vaccine to protect you against lower respiratory tract disease caused by Respiratory Syncytial Virus (RSV).

mRESVIA is for people 60 years of age and older and also for people 18 through 59 years of age who are at increased risk for RSV (people with medical conditions such as diabetes or with diseases affecting the lungs and heart). Vaccination with mRESVIA may not protect all people who receive the vaccine.

mRESVIA does not contain RSV. mRESVIA cannot give you lower respiratory tract disease caused by RSV.

IMPORTANT SAFETY INFORMATION

Who should not get mRESVIA?

You should not get mRESVIA if you had a severe allergic reaction to any ingredient in mRESVIA.

What should you tell your healthcare provider?

Tell your healthcare provider about all of your medical conditions, including if you:

• Have any allergies

• Had a severe allergic reaction after receiving a previous dose of any other vaccine

• Have a fever

• Have a bleeding disorder or are on a blood thinner

• Are immunocompromised or are on a medicine that affects your immune system

• Have received any other RSV vaccine

• Have ever fainted in association with an injection

How is mRESVIA given?

mRESVIA is given as an injection into the muscle.

What are the risks of mRESVIA?

There is a very small chance that mRESVIA could cause a severe allergic reaction. A severe allergic reaction would usually occur within a few minutes to one hour after getting a dose of mRESVIA. For this reason, your healthcare provider may ask you to stay for a short time at the place where you received your vaccine. Signs of a severe allergic reaction may include:

• Trouble breathing

• Swelling of your face and throat

• A fast heartbeat

• A rash all over your body

• Dizziness and weakness

Side effects that have been reported in clinical trials with mRESVIA include:

• Injection-site reactions: pain, underarm swelling or tenderness in the same arm of the injection, swelling (hardness), and redness

• Fatigue, headache, muscle pain, joint pain, chills, nausea or vomiting, fever and hives

These may not be all of the possible side effects of mRESVIA. Ask your healthcare provider about any side effects that concern you. You may report side effects to the Vaccine Adverse Event Reporting System (VAERS) at 1-800-822-7967 or https://vaers.hhs.gov.

Please click for mRESVIA Full Prescribing Information.

Moderna Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding: the efficacy, safety and tolerability of mRESVIA; the disease burden associated with RSV, particularly in adults with certain risk factors; and the availability of mRESVIA for the 2025-2026 season. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna’s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others, those risks and uncertainties described under the heading “Risk Factors” in Moderna’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and in subsequent filings made by Moderna with the U.S. Securities and Exchange Commission, which are available on the SEC’s website at www.sec.gov. Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna’s current expectations and speak only as of the date of this press release.

Moderna Contacts

Media:
Chris Ridley
Head of Global Media Relations
+1 617-800-3651
Chris.Ridley@modernatx.com

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
+1 617-209-5834
Lavina.Talukdar@modernatx.com

³ Weycker D, Averin A, Houde L, et al. Rates of Lower Respiratory Tract Illness in US Adults by Age and Comorbidity Profile. Infect Dis Ther 2024; 13(1): 207-20.

SOURCE: Moderna, Inc.

View the original press release on ACCESS Newswire

BROOKLYN, NY / ACCESS Newswire / June 12, 2025 / IEH Corporation (OTC PINK:IEHC) today filed with the Securities and Exchange Commission (SEC) its Annual Report on Form 10-K for the fiscal year ended March 31, 2025.

Highlights include:

• 34% Increase in Revenue over Fiscal Year 2024

• $4.34M Improvement in Operating Income

• 72% increase in cash on hand, compared to prior year

For the Fiscal Year ended March 31, 2025, IEH had revenues of $28,783,861 as compared to $21,524,544 for the Fiscal Year ended March 31, 2024 reflecting a 33.7% increase; operating income of $574,862 for Fiscal Year 2025 as compared to an operating loss of $3,760,887 for Fiscal Year 2024 reflecting a $4,335,749 improvement; net income of $999,038 for Fiscal Year 2025 as compared to a net loss of $2,916,902 for Fiscal Year 2024 reflecting a $3,915,940 improvement; and a basic earnings per share of $.42 as compared to a basic loss per share of $1.23 for Fiscal Year 2024.

Dave Offerman, President and CEO of IEH Corporation commented, “By almost any discernible metric, IEH’s financial health has improved considerably this past year. Our revenue was 3^rd-highest in our history, our cash position has improved dramatically since this time last year, inventory relative to revenue is down, and we were profitable in both operating and net income. Our margins continue to be lower than desired due to the rise in our material costs, but price adjustments implemented over the last several months will bolster our gross margins going forward and be reflected in future financial statements. After declining for several months, our backlog has stabilized, and our sales pipeline remains strong. Changes in the competitive landscape offer opportunities to win market share, and we continue to intensify our marketing efforts to target new industries for our signature Hyperboloid products.

As previously noted, growth and improvements may still be uneven from one quarter to the next while the commercial aircraft industry continues to produce below their target levels, but our long-term forecasts for that sector, along with strong growth projections in our defense-related business and commercial space launch bode well for IEH in the years ahead.

So while it’s possible that revenue in Fiscal Year 2026 will be slightly lower than 2025, the overall strength of our sales pipeline, along with efforts underway to improve our product mix and diversify our markets served, should lead to considerable long-term growth.

On behalf of the management team and staff of IEH, we again wish to express our sincere gratitude for the support of our valued shareholders. We look forward to sharing more positive news in the coming months and quarters.”

About IEH Corporation

For over 80 years and 4 generations of family-run management, IEH Corporation has designed, developed, and manufactured printed circuit board (PCB) connectors, custom interconnects and contacts for high performance applications. With its signature Hyperboloid technology, IEH supplies the most durable, reliable connectors for the most demanding environments. The Company markets primarily to companies in defense, aerospace, medical, space and industrial applications, in the United States, Canada, Europe, Southeast and Central Asia and the Mideast. The Company was founded in 1941 and is headquartered in Brooklyn, New York.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Certain statements contained in this press release, and in related comments by the Company’s management, include “forward-looking statements.” All statements, other than statements of historical facts, including, without limitation, statements or expectations regarding our financial condition, statements or expectations regarding our revenues, cash and backlog, expectations regarding future cash requirements, revenue and revenue recovery, including for fiscal year 2026 and beyond, projected timelines for making our SEC filings or successfully preventing our registration from suspension or revocation and expectations regarding our efforts and ability to resolve our inventory accounting issues are forward-looking statements. These statements often include words such as “believe,” “expect,” “estimate,” “plan,” “will,” “may,” “would,” “should,” “could,” or similar expressions, although not all forward-looking statements contain such identifying words. These statements are based on certain assumptions that the Company has made on its current expectations and projections about future events. The Company believes these judgments are reasonable, but you should understand that these statements are not guarantees of performance or results, and you should not place undue reliance on any forward-looking statements. The Company’s actual performance or results could differ materially from those expressed in the forward-looking statements due to a variety of important factors, both positive and negative, as they will depend on many factors about which we are unsure, including many factors beyond our control. Among other items, such factors could include: any claims, investigations or proceedings arising as a result of our past due periodic reports, including changes in the proceedings related to the SEC’s Order Instituting Administrative Proceedings and Notice of Hearing pursuant to Section 12(j) of the Securities and Exchange Act of 1934, as amended; our ability to remediate our inventory accounting issue; our ability to reduce costs or increase revenue; changes in the macroeconomic environment or in the finances of our customers; changes in accounting principles, or their application or interpretation, and our ability to make accurate estimates and the assumptions underlying the estimates; our ability to attract and retain key employees and key resources; and other risk factors discussed from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on June 12, 2025, and in subsequent reports filed with or furnished to the SEC. Additional information concerning these and other factors can be found in our filings with the SEC. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by the foregoing cautionary statements. Except as may be required by applicable law, we do not undertake or intend to update or revise our forward-looking statements, and we assume no obligation to update any forward-looking statements contained in this press release as a result of new information or future events or developments. Thus, you should not assume that our silence over time means that actual events are bearing out as expressed or implied in such forward-looking statements. You should carefully review and consider the various disclosures we make in our filings with the SEC that attempt to advise interested parties of the risks, uncertainties and other factors that may affect our business.

Contact:

Dave Offerman
IEH Corporation
dave@iehcorp.com
718-492-4448

SOURCE: IEH Corp.

View the original press release on ACCESS Newswire

The campaign will air nationally on CNBC, FOX Business, Bloomberg, and inside NTTS’s weekly investor-focused television broadcasts-along with distribution across New to The Street’s 2.6M YouTube subscriber channel.

NEW YORK CITY, NY / ACCESS Newswire / June 12, 2025 / New to The Street, a leading multi-platform financial media brand, proudly announces the launch of a new national commercial campaign for its featured client, Arrive AI (NASDAQ:ARAI). The high-impact TV commercial will be distributed across major financial news networks including CNBC, FOX Business, and Bloomberg, and will be fully integrated into New to The Street’s weekly syndicated TV series reaching more than 220 million U.S. homes.

View commercial now:

The spot will also air across New to The Street’s powerful digital network-including its YouTube channel with over 2.6 million subscribers, one of the largest financial video audiences in the world.

The campaign shines a spotlight on Arrive AI’s patented autonomous delivery platform, emphasizing its smart mailbox technology, U.S. patent portfolio, and its game-changing use cases in healthcare, e-commerce, and temperature-sensitive logistics. It’s a critical moment of visibility for the company as it accelerates commercialization and expands across new sectors.

“Arrive AI is one of the most compelling companies we’ve ever featured,” said Vince Caruso, Creator and Host of New to The Street. “This TV campaign will bring their message to millions of investors, partners, and consumers across all our channels-network TV, outdoor, digital, and our 2.6M-strong YouTube community. We’re proud to help tell their story at scale.”

The commercial will be seen:

• Inside New to The Street’s nationally broadcast segments on FOX Business and Bloomberg

• On CNBC through targeted prime-time media placements

• Digitally across New to The Street’s YouTube Channel (2.6M+ subscribers)

• Programmatically distributed across OTT platforms and digital pre-roll

• Through Accel Media’s iconic outdoor billboard network including Times Square and NYC Financial District

The full-scale media rollout is expected to support upcoming milestones for Arrive AI, including new strategic partnerships, vertical expansion, and additional product announcements.

About Arrive AI (NASDAQ:ARAI):
Arrive AI is building the future of smart logistics with its patented Arrive Points™-AI-powered mailboxes designed to securely manage both autonomous and traditional package deliveries. With eight issued patents and a growing presence in healthcare, e-commerce, and industrial delivery, Arrive AI is revolutionizing last-mile fulfillment infrastructure.

About New to The Street:
New to The Street is a nationally televised business show that features public and private companies, airing as sponsored programming on FOX Business, Bloomberg, and CNBC. It also operates one of the largest financial YouTube channels in the U.S. with over 2.6 million subscribers, supported by robust earned media, digital distribution, and outdoor advertising in Times Square and the NYC Financial District.

Media Contact:
Monica Brennan
PR, New to The Street
Monica@NewToTheStreet.com

Investor Contact:
Dan O’Toole, CEO, Arrive AI
ir@arrive.ai

SOURCE: New To The Street

View the original press release on ACCESS Newswire

NEW YORK CITY, NY / ACCESS Newswire / June 12, 2025 / On June 11, 2025, Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq:ADUR)(CSE:ACT)(FSE:9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, announced the closing of its underwritten U.S. public offering (the “Offering”) of 947,868 common shares, together with accompanying warrants to purchase 473,934 common shares. The combined public offering price per common share and accompanying half warrant was US$8.44. The Company received gross proceeds of approximately US$8 million, before deducting underwriting discounts and offering expenses. The common shares were sold in combination with an accompanying half warrant (with each whole warrant being exercisable into one common share of the Company). Each whole warrant has an exercise price of US$10.13 per share and are exercisable immediately and will expire three years from the date of issuance.

Acting as the sole book-running manager for the Offering, D. Boral Capital LLC worked closely with Aduro Clean Technologies’s experience CFO, Mr. Mena Beshay on planning and executing this successful transaction.

Aduro intends to use the net proceeds from the offering for ongoing research and development costs, expenditures related to the construction of its “Demonstration-Scale” plant and the remainder (if any) for general corporate purposes and working capital.

In addition, the Company has granted the underwriters a 45-day over-allotment option to purchase up to an additional 142,180 common shares and/or warrants to purchase an additional 71,090 common shares.

The Offering was being made pursuant to an effective shelf registration statement on Form F-10, as amended (File No. 333-287475), previously filed with the U.S. Securities and Exchange Commission (“SEC”) and became effective on May 28, 2025, and the Company’s Canadian short form base shelf prospectus dated May 28, 2025 (the “Base Shelf Prospectus”). Aduro offered and sold the securities in the United States only. No securities were offered or sold to Canadian purchasers.

The Base Shelf Prospectus relating to the Offering and describing the terms thereof has been filed with the applicable securities commissions in Canada and with the SEC in the United States and is available for free by visiting the Company’s profiles on the SEDAR+ website maintained by the Canadian Securities Administrators at www.sedarplus.ca or the SEC’s website at www.sec.gov, as applicable. A final prospectus supplement with the final terms will be filed with the securities regulatory authorities in the Canadian provinces of British Columbia and Ontario and the SEC.

Copies of the final prospectus may be obtained, when available, at the SEC’s website at www.sec.gov or from D. Boral Capital LLC, Attention: 590 Madison Avenue 39th Floor, New York, NY 10022, or by email at dbccapitalmarkets@dboralcapital.com, or by telephone at +1 (212) 970-5150.

Before you invest, you should read the prospectus and other documents the Company has filed or will file with the SEC for more complete information about the Company and the Offering. This press release shall not constitute an offer to sell, or the solicitation of an offer to buy any of the Company’s securities, nor shall such securities be offered or sold in the United States absent registration or an applicable exemption from registration, nor shall there be any offer, solicitation or sale of any of the Company’s securities in any state or jurisdiction in which such offers, solicitations or sales would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

About Aduro Clean Technologies

Aduro Clean Technologies is a developer of patented water-based technologies to chemically recycle waste plastics; convert heavy crude and bitumen into lighter, more valuable oil; and transform renewable oils into higher-value fuels or renewable chemicals. The Company’s Hydrochemolytic™ Technology relies on water as a critical agent in a chemistry platform that operates at relatively low temperatures and cost, a game-changing approach that converts low-value feedstocks into resources for the 21st century.

About D. Boral Capital

D. Boral Capital LLC is a premier, relationship-driven global investment bank headquartered in New York. The firm is dedicated to delivering exceptional strategic advisory and tailored financial solutions to middle-market and emerging growth companies. With a proven track record, D. Boral Capital provides expert guidance to clients across diverse sectors worldwide, leveraging access to capital from key markets, including the United States, Asia, Europe, the Middle East, and Latin America.

A recognized leader on Wall Street, D. Boral Capital has successfully aggregated approximately $30 billion in capital since its inception in 2020, executing ~350 transactions across a broad range of investment banking products.

Forward-Looking Statement

This press release contains forward-looking statements regarding the Company’s current expectations. These forward-looking statements include, without limitation, references to the Company’s expectations regarding anticipated use of net proceeds from the Offering. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, risks and uncertainties related to the factors that may result in changes to the Company’s anticipated use of proceeds. These and other risks and uncertainties are described more fully in the section captioned “Risk Factors” in the Company’s annual information form dated May 20, 2025, which is available on SEDAR+ at www.sedarplus.ca, on EDGAR at www.sec.gov. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law, including the securities laws of the United States and Canada.

For more information, please contact:

D. Boral Capital LLC
Email: dbccapitalmarkets@dboralcapital.com
Telephone: +1(212) 970-5150

SOURCE: D. Boral Capital

View the original press release on ACCESS Newswire